Real-World Genomic Profile of EGFR Second-Site Mutations and Other Osimertinib Resistance Mechanisms and Clinical Landscape of NSCLC Post-Osimertinib
- Resource Type
- Article
- Source
- In
Journal of Thoracic Oncology February 2024 19(2):227-239 - Subject
- Language
- ISSN
- 1556-0864